Seong, D <br/><br/>
Usefulness of detection of minimal residual disease by 'hypermetaphase' fluorescent in situ hybridization after allogeneic BMT for chronic myelogenous leukemia.  [electronic resource] 

 -  Bone marrow transplantation  Mar 1997 
 - 565-70 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>0268-3369 
<br/><br/><label>Standard No.: </label>10.1038/sj.bmt.1700700  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ABO Blood-Group System<br/>Adult<br/>Bone Marrow--ultrastructure<br/>Bone Marrow Transplantation<br/>Female<br/>Humans<br/>In Situ Hybridization, Fluorescence<br/>Karyotyping<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--blood<br/>Transplantation, Homologous